Mitocondria Revenue and Competitors
Estimated Revenue & Valuation
- Mitocondria's estimated annual revenue is currently $1.7M per year.
- Mitocondria's estimated revenue per employee is $87,000
Employee Data
- Mitocondria has 19 Employees.
- Mitocondria grew their employee count by 6% last year.
Mitocondria Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $57.6M | 318 | 24% | N/A | N/A |
#2 | $44.6M | 286 | 23% | $25.4M | N/A |
#3 | $5.1M | 44 | -6% | N/A | N/A |
#4 | $35.1M | 225 | -3% | $46.9M | N/A |
#5 | $14.5M | 100 | 5% | N/A | N/A |
#6 | $1.3M | 15 | -6% | N/A | N/A |
#7 | $1.5M | 17 | 0% | N/A | N/A |
#8 | $2.9M | 29 | -12% | N/A | N/A |
#9 | $125.2M | 691 | 6% | N/A | N/A |
#10 | $95.9M | 529 | -1% | N/A | N/A |
What Is Mitocondria?
Nuestro corazón es la comunicación, el diseño y la tecnologÃa. Nos apasiona crear soluciones innovadoras y eficientes, que van más allá de lo posible. Somos un gran equipo de Ingenieros, Diseñadores, Publicistas, Redactores, Directores de Arte, Ejecutivos, Directores, Programadores... Somos muchas voces, en una sola frecuencia.
keywords:N/A
N/A
Total Funding
19
Number of Employees
$1.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mitocondria News
La cuantificación de las actividades enzimáticas de la cadena respiratoria mitocondrial (CRM) es fundamental para el diagnóstico de una gran...
A mitocôndria é uma organela vital para o organismo, pois produz, ... da função mitocondrial esteja associado ao aumento da longevidade.
Karina Ninni | Agência FAPESP A mitocôndria é uma organela vital para o organismo, pois produz, a partir dos alimentos, a maior parte da...
Other Companies in Santiago de Chile
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.1M | 27 | -29% | N/A |
#2 | $2.7M | 28 | 12% | N/A |
#3 | $9.6M | 37 | -14% | N/A |
#4 | $9.6M | 37 | -14% | N/A |
#5 | $9.6M | 37 | -14% | N/A |